140 related articles for article (PubMed ID: 30928180)
1. Neurochemical effects of oxytocin in people at clinical high risk for psychosis.
Davies C; Rutigliano G; De Micheli A; Stone JM; Ramella-Cravaro V; Provenzani U; Cappucciati M; Scutt E; Paloyelis Y; Oliver D; Murguia S; Zelaya F; Allen P; Shergill S; Morrison P; Williams S; Taylor D; Lythgoe DJ; McGuire P; Fusar-Poli P
Eur Neuropsychopharmacol; 2019 May; 29(5):601-615. PubMed ID: 30928180
[TBL] [Abstract][Full Text] [Related]
2. Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis.
Davies C; Paloyelis Y; Rutigliano G; Cappucciati M; De Micheli A; Ramella-Cravaro V; Provenzani U; Antoniades M; Modinos G; Oliver D; Stahl D; Murguia S; Zelaya F; Allen P; Shergill S; Morrison P; Williams S; Taylor D; McGuire P; Fusar-Poli P
Neuropsychopharmacology; 2019 Jun; 44(7):1300-1309. PubMed ID: 30626906
[TBL] [Abstract][Full Text] [Related]
3. Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin.
Davies C; Martins D; Dipasquale O; McCutcheon RA; De Micheli A; Ramella-Cravaro V; Provenzani U; Rutigliano G; Cappucciati M; Oliver D; Williams S; Zelaya F; Allen P; Murguia S; Taylor D; Shergill S; Morrison P; McGuire P; Paloyelis Y; Fusar-Poli P
Mol Psychiatry; 2024 May; 29(5):1241-1252. PubMed ID: 38243074
[TBL] [Abstract][Full Text] [Related]
4. Regional Myo-Inositol, Creatine, and Choline Levels Are Higher at Older Age and Scale Negatively with Visuospatial Working Memory: A Cross-Sectional Proton MR Spectroscopy Study at 7 Tesla on Normal Cognitive Ageing.
Lind A; Boraxbekk CJ; Petersen ET; Paulson OB; Siebner HR; Marsman A
J Neurosci; 2020 Oct; 40(42):8149-8159. PubMed ID: 32994337
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol modulation of hippocampal glutamate in early psychosis.
O'Neill A; Annibale L; Blest-Hopley G; Wilson R; Giampietro V; Bhattacharyya S
J Psychopharmacol; 2021 Jul; 35(7):814-822. PubMed ID: 33860709
[TBL] [Abstract][Full Text] [Related]
6. Association of Hippocampal Glutamate Levels With Adverse Outcomes in Individuals at Clinical High Risk for Psychosis.
Bossong MG; Antoniades M; Azis M; Samson C; Quinn B; Bonoldi I; Modinos G; Perez J; Howes OD; Stone JM; Allen P; McGuire P
JAMA Psychiatry; 2019 Feb; 76(2):199-207. PubMed ID: 30427993
[TBL] [Abstract][Full Text] [Related]
7. Hippocampal glutamate metabolites and glial activation in clinical high risk and first episode psychosis.
Shakory S; Watts JJ; Hafizi S; Da Silva T; Khan S; Kiang M; Bagby RM; Chavez S; Mizrahi R
Neuropsychopharmacology; 2018 Oct; 43(11):2249-2255. PubMed ID: 30087434
[TBL] [Abstract][Full Text] [Related]
8. Corticolimbic hyper-response to emotion and glutamatergic function in people with high schizotypy: a multimodal fMRI-MRS study.
Modinos G; McLaughlin A; Egerton A; McMullen K; Kumari V; Barker GJ; Keysers C; Williams SC
Transl Psychiatry; 2017 Apr; 7(4):e1083. PubMed ID: 28375210
[TBL] [Abstract][Full Text] [Related]
9. Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
Natsubori T; Inoue H; Abe O; Takano Y; Iwashiro N; Aoki Y; Koike S; Yahata N; Katsura M; Gonoi W; Sasaki H; Takao H; Kasai K; Yamasue H
Schizophr Bull; 2014 Sep; 40(5):1128-39. PubMed ID: 24023251
[TBL] [Abstract][Full Text] [Related]
10. Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosis.
Schmidt A; Davies C; Paloyelis Y; Meyer N; De Micheli A; Ramella-Cravaro V; Provenzani U; Aoki Y; Rutigliano G; Cappucciati M; Oliver D; Murguia S; Zelaya F; Allen P; Shergill S; Morrison P; Williams S; Taylor D; Borgwardt S; Yamasue H; McGuire P; Fusar-Poli P
Transl Psychiatry; 2020 Jun; 10(1):203. PubMed ID: 32572020
[TBL] [Abstract][Full Text] [Related]
11. Glutamatergic function in a genetic high-risk group for psychosis: A proton magnetic resonance spectroscopy study in individuals with 22q11.2 deletion.
Rogdaki M; Hathway P; Gudbrandsen M; McCutcheon RA; Jauhar S; Daly E; Howes O
Eur Neuropsychopharmacol; 2019 Dec; 29(12):1333-1342. PubMed ID: 31648854
[TBL] [Abstract][Full Text] [Related]
12. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
[TBL] [Abstract][Full Text] [Related]
13. Ethyl-eicosapentaenoic acid in first-episode psychosis. A 1H-MRS study.
Berger GE; Wood SJ; Wellard RM; Proffitt TM; McConchie M; Amminger GP; Jackson GD; Velakoulis D; Pantelis C; McGorry PD
Neuropsychopharmacology; 2008 Sep; 33(10):2467-73. PubMed ID: 18199999
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.
Yoo SY; Yeon S; Choi CH; Kang DH; Lee JM; Shin NY; Jung WH; Choi JS; Jang DP; Kwon JS
Schizophr Res; 2009 Jun; 111(1-3):86-93. PubMed ID: 19406622
[TBL] [Abstract][Full Text] [Related]
15. Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis.
Bojesen KB; Ebdrup BH; Jessen K; Sigvard A; Tangmose K; Edden RAE; Larsson HBW; Rostrup E; Broberg BV; Glenthøj BY
Psychol Med; 2020 Oct; 50(13):2182-2193. PubMed ID: 31524118
[TBL] [Abstract][Full Text] [Related]
16. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.
Yildiz-Yesiloglu A; Ankerst DP
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):969-95. PubMed ID: 16677749
[TBL] [Abstract][Full Text] [Related]
17. A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.
Reid MA; White DM; Kraguljac NV; Lahti AC
Schizophr Res; 2016 Feb; 170(2-3):341-50. PubMed ID: 26718333
[TBL] [Abstract][Full Text] [Related]
18. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania.
Öngür D; Jensen JE; Prescot AP; Stork C; Lundy M; Cohen BM; Renshaw PF
Biol Psychiatry; 2008 Oct; 64(8):718-726. PubMed ID: 18602089
[TBL] [Abstract][Full Text] [Related]
19. (1)H-magnetic resonance spectroscopy ((1)H-MRS) in methamphetamine dependence and methamphetamine induced psychosis.
Howells FM; Uhlmann A; Temmingh H; Sinclair H; Meintjes E; Wilson D; Stein DJ
Schizophr Res; 2014 Mar; 153(1-3):122-8. PubMed ID: 24529366
[TBL] [Abstract][Full Text] [Related]
20. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
